Nektar Therapeutics Senior Notes, Current
Nektar Therapeutics (NKTR) had Senior Notes, Current of $0 as of 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:SeniorNotesCurrent · last filed 2021-02-26
- 2020-12-31: Senior Notes, Current $0.00.
- 2020-09-30: Senior Notes, Current $0.00.
- 2020-06-30: Senior Notes, Current $0.00.
- 2020-03-31: Senior Notes, Current $254.14M.
| Period end | Senior Notes, Current | Senior Notes, Current as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-26 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $254.14M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $252.89M 10-K · filed 2021-02-26 | $248.69M 10-K · filed 2020-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-28 | |
| 2015-09-30 | $125.00M 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |